Prednisone

Small Intestine Cancer

City of Hope Medical CenterSmall moleculePhase 2Dormant

B

63/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 52/ 100
Competitive Position: 81/ 100

Competitive context

19 Active assets in the Small Intestine Cancer cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide National Cancer Institute (NCI)	Phase 2	BB
Etoposide Cancer Research UK	Phase 2	BB
Vincristine Sulfate Cancer Research UK	Phase 2	BB
Nivestim Cancer Research UK	Phase 2	BB
Carboplatin National Cancer Institute (NCI)	Phase 2	B

View all 49 →

Same molecule, other indications

Prednisone is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant

BBB

Indicative · Phase 3

74 / 100

diffuse large B-cell lymphomaActive

BBB

Indicative · Phase 4

74 / 100

peripheral T-cell lymphoma, not otherwise specifiedActive

BBB

Indicative · Phase 4

74 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.